Delivery Order SPE2DB20D2014-SPE2DB25FB14Z

Award Date 2/21/25
Potential Completion Date 3/14/25
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,671.23 firm-fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,634.70 firm-fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML medical products, with a period of performance through February 27, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $18,636.48 firm fixed-price contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract is not designated as a set-aside and has an ultimate completion date of November 6, 2024. Amerisourcebergen Drug Corp holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,684.92 Firm Fixed Price Delivery Order contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,213.40 firm fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,826.00 firm fixed-price delivery order is for the supply of 4564622502 - AVEED 750 MG/3 ML VIAL 3ML, with a period of performance through May 31, 2024. This award is not designated as a set-aside contract. AmerisourceBergen maintains a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a Delivery Order valued at $7,707.76 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a medical product, with a performance period ending on February 14, 2025. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AVEED 750 MG/3 ML VIAL 3ML medical products. The contract, valued at $8,033.50, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price contract. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,882.60 firm fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. This contract does not have a set-aside designation. The award is likely part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $18,636.48, is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a prescription medication. This is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB14Z
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,634.70 firm fixed-price delivery order is for AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product.

The contract is not designated as a set-aside. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/23/25, 10:04 AM